Muñoz Torres E, Abad Hernández M M, López Bravo A, Alonso Martín M J, Paz Bouza J I
An Med Interna. 1989 Apr;6(4):189-91.
Liver cirrhosis is a very common illnesses and currently its treatment remains unpromising. In a research line devoted to studying the hepatotoxicity of certain substances we have evaluated the lesions that appear prior to the occurrence of cirrhosis and hepatocarcinoma in order to test, in different assays liver-protecting substances such as cyanidanol-3 that have been seen to lead to an improvement in morphological alterations in the liver and even to reverse such lesions. The mechanisms of action of this compound are discussed. The authors believe that considerable work remains to be carried out but that some day some liver-protecting substances that yield good experimental results may be applied to clinical situations.
肝硬化是一种非常常见的疾病,目前其治疗前景依然不容乐观。在一项致力于研究某些物质肝毒性的研究中,我们评估了肝硬化和肝癌发生之前出现的病变,以便在不同的试验中测试诸如3 - 氰基酚等具有肝脏保护作用的物质,这些物质已被证明可改善肝脏的形态学改变,甚至逆转此类病变。本文还讨论了该化合物的作用机制。作者认为仍有大量工作有待开展,但终有一天,一些在实验中取得良好效果的肝脏保护物质可能会应用于临床。